Nash Michael J, Cohen Hannah
Department of Haematology, University College London Hospitals NHS Trust, Grafton Way, London, UK.
Blood Rev. 2004 Sep;18(3):211-7. doi: 10.1016/S0268-960X(03)00065-1.
The management of practising Jehovah's Witnesses who have haematological problems presents many different challenges both at the level of treatment strategy and ethics. This article focuses on the beliefs of Jehovah's Witnesses and addresses treatment modalities available for and acceptable to these individuals. Recent advances in the development of novel therapeutic agents have aided the management of Jehovah's Witnesses. Finally, the background to the ethical dilemmas raised by these issues is discussed.
对患有血液学问题的耶和华见证会信徒进行管理，在治疗策略和伦理层面都带来了诸多不同的挑战。本文聚焦于耶和华见证会的信仰，并探讨适用于这些信徒且为他们所接受的治疗方式。新型治疗药物研发的最新进展有助于对耶和华见证会信徒的管理。最后，讨论了这些问题引发的伦理困境的背景。
Zotero 插件